Table of Contents Author Guidelines Submit a Manuscript
Journal of Analytical Methods in Chemistry
Volume 2017 (2017), Article ID 6749087, 7 pages
https://doi.org/10.1155/2017/6749087
Research Article

Simultaneous Determination of Dexamethasone, Ondansetron, Granisetron, Tropisetron, and Azasetron in Infusion Samples by HPLC with DAD Detection

1Department of Pharmacy, Dongfeng Hospital, Hubei University of Medicine, Shiyan, Hubei 442008, China
2Department of Pharmacy, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, China
3Department of Oncology, Dongfeng Hospital, Hubei University of Medicine, Shiyan, Hubei 442008, China

Correspondence should be addressed to Bao-xia Fang; moc.361@501118-xbf

Received 21 October 2016; Accepted 19 December 2016; Published 11 January 2017

Academic Editor: Chih-Ching Huang

Copyright © 2017 Fu-chao Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Rosenblatt, L. M. Lev, and E. Robinson, “High-dose dexamethasone and high-dose metoclopramide versus high-dose dexamethasone and sulpiride in the management of cisplatin-induced emesis,” Oncology, vol. 45, no. 4, pp. 297–299, 1988. View at Publisher · View at Google Scholar · View at Scopus
  2. M. S. Aapro and D. S. Alberts, “Dexamethasone as an antiemetic in patients treated with cisplatin,” New England Journal of Medicine, vol. 305, no. 9, p. 520, 1981. View at Google Scholar · View at Scopus
  3. A. C. Tricco, C. Soobiah, E. Blondal et al., “Comparative efficacy of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis,” BMC Medicine, vol. 13, no. 1, article no. 136, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. G. McCracken, P. Houston, and G. Lefebvre, “Guideline for the management of postoperative nausea and vomiting,” Journal of Obstetrics and Gynaecology Canada, vol. 30, no. 7, pp. 600–607, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. T. K. MacHu, “Therapeutics of 5-HT3 receptor antagonists: current uses and future directions,” Pharmacology and Therapeutics, vol. 130, no. 3, pp. 338–347, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. D. A. Perwitasari, H. Gelderblom, J. Atthobari et al., “Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics,” International Journal of Clinical Pharmacy, vol. 33, no. 1, pp. 33–43, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Ithimakin, K. Runglodvatana, A. Nimmannit et al., “Randomized, double-blinded, placebo-controlled trial of ondansetron plus dexamethasone with or without metoclopramide as antiemetic prophylaxis in patients receiving high-dose cisplatin in medical practice,” Supportive Care in Cancer, vol. 20, no. 4, pp. 849–855, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Saito, K. Aogi, I. Sekine et al., “Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial,” The Lancet Oncology, vol. 10, no. 2, pp. 115–124, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. D. T. T. Chua, J. S. T. Sham, D. L. W. Kwong et al., “Comparative efficacy of three 5-HT3 antagonists (granisetron, ondansetron, and tropisetron) plus dexamethasone for the prevention of cisplatin-induced acute emesis: a randomized crossover study,” American Journal of Clinical Oncology, vol. 23, no. 2, pp. 185–191, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Hayakawa, M. Sato, M. Konaka et al., “Comparison of ramosetron and azasetron for prevention of acute and delayed cisplatin-induced emesis in lung cancer patients,” Cancer & Chemotherapy, vol. 33, no. 5, pp. 633–638, 2006. View at Google Scholar · View at Scopus
  11. F.-C. Chen, J. Zhu, B. Li, F.-J. Yuan, and L.-H. Wang, “Stability of tramadol with three 5-HT3 receptor antagonists in polyolefin bags for patient-controlled delivery systems,” Drug Design, Development and Therapy, vol. 10, pp. 1869–1875, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Bourdon, M. Lecoeur, P. Odou, C. Vaccher, and C. Foulon, “Complementarity of UV-PLS and HPLC for the simultaneous evaluation of antiemetic drugs,” Talanta, vol. 120, pp. 274–282, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Bougouin, C. Thelcide, F. Crespin-Maillard, C. Maillard, J. M. Kinowski, and M. Favier, “Compatibility of ondansetron hydrochloride and methylprednisolone sodium succinate in multilayer polyolefin containers,” American Journal of Health-System Pharmacy, vol. 62, no. 19, pp. 2001–2005, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Bauer, E. Strmer, R. Kaiser, P.-B. Tremblay, J. Brockmller, and I. Roots, “Simultaneous determination of ondansetron and tropisetron in human plasma using HPLC with UV detection,” Biomedical Chromatography, vol. 16, no. 3, pp. 187–190, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. H. AlAani and Y. Alnukkary, “Stability-indicating HPLC method for simultaneous determination of chloramphenicol, dexamethasone sodium phosphate and tetrahydrozoline hydrochloride in ophthalmic solution,” Advanced Pharmaceutical Bulletin, vol. 6, no. 1, pp. 137–141, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. V. D. Hoang, N. T. Hue, N. H. Tho, and H. M. T. Nguyen, “Simultaneous determination of chloramphenicol, dexamethasone and naphazoline in ternary and quaternary mixtures by RP-HPLC, derivative and wavelet transforms of UV ratio spectra,” Spectrochimica Acta—Part A: Molecular & Biomolecular Spectroscopy, vol. 139, pp. 20–27, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. A. A. Heda, J. M. Kathiriya, D. D. Gadade, and P. K. Puranik, “Development and validation of RP-HPLC method for simultaneous determination of granisetron and dexamethasone,” Indian Journal of Pharmaceutical Sciences, vol. 73, no. 6, pp. 696–699, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Negro, A. Salama, Y. Sánchez, M. L. Azuara, and E. Barcia, “Compatibility and stability of tramadol and dexamethasone in solution and its use in terminally ill patients,” Journal of Clinical Pharmacy & Therapeutics, vol. 32, no. 5, pp. 441–444, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Pinguet, P. Rouanet, P. Martel, M. Fabbro, D. Salabert, and C. Astre, “Compatibility and stability of granisetron, dexamethasone, and methylprednisolone in injectable solutions,” Journal of Pharmaceutical Sciences, vol. 84, no. 2, pp. 267–268, 1995. View at Publisher · View at Google Scholar · View at Scopus
  20. R. L. Hagan, M. S. Mallett, and J. L. Fox, “Stability of ondansetron hydrochloride and dexamethasone sodium phosphate in infusion bags and syringes for 32 days,” American Journal of Health-System Pharmacy, vol. 53, no. 12, pp. 1431–1435, 1996. View at Google Scholar · View at Scopus
  21. C. R. Anderson, Z. Halford, and M. MacKay, “Stability of diphenhydramine hydrochloride, lorazepam, and dexamethasone sodium phosphate in 0.9% sodium chloride stored in polypropylene syringes,” International Journal of Pharmaceutical Compounding, vol. 19, no. 4, pp. 344–347, 2015. View at Google Scholar · View at Scopus
  22. A. Chin, Y. S. K. Moon, K. C. Chung, and M. A. Gill, “Stability of granisetron hydrochloride with dexamethasone sodium phosphate for 14 days,” American Journal of Health-System Pharmacy, vol. 53, no. 10, pp. 1174–1176, 1996. View at Google Scholar · View at Scopus
  23. S. E. Walker and S. Law, “Stability and compatibility of granisetron alone and combination with dexamethasone in 0.9% sodium chloride and 5% dextrose in water solutions,” Canadian Journal of Hospital Pharmacy, vol. 55, no. 1, pp. 27–38, 2002. View at Google Scholar · View at Scopus
  24. S. Y. Um, S. W. Chae, H. J. Park, M. W. Chung, S. O. Choi, and H. J. Lee, “Simple determination of azasetron in rat plasma by column-switching high-performance liquid chromatography,” Journal of Separation Science, vol. 33, no. 23-24, pp. 3638–3643, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. F.-C. Chen, H. Xiong, H.-M. Liu, B.-X. Fang, and P. Li, “Compatibility of butorphanol with granisetron in 0.9% sodium chloride injection packaged in glass bottles or polyolefin bags,” American Journal of Health-System Pharmacy, vol. 72, no. 16, pp. 1374–1378, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. T. G. Venkateshwaran, D. T. King, and J. T. Stewart, “HPLC determination of a metoclopramide and ondansetron mixture in 0.9% sodium chloride injection,” Journal of Liquid Chromatography, vol. 18, no. 1, pp. 117–126, 1995. View at Publisher · View at Google Scholar · View at Scopus
  27. R. P. Shirish, L. J. Patel, P. T. Yogeshvar, and D. P. Nimesh, “Development and validation of analytical method for the determination of rabeprazole and ondansetron in pharmaceutical dosage form by reversed-phase HPLC,” International Journal of Chemtech Research Coden, vol. 2, no. 3, pp. 1531–1536, 2010. View at Google Scholar
  28. Z. Dedania, R. Dedania, V. Karkhanis et al., “RP-HPLC method for simultaneous estimation of omeprazole and ondansetron in combined dosage forms,” Asian Journal of Research in Chemistry, vol. 2, no. 2, pp. 108–111, 2009. View at Google Scholar
  29. A. Suneetha and T. Chandana Priya, “RP-HPLC method for simultaneous estimation of paracetamol and ondansetron in bulk & oral suspension,” Journal of Pharmaceutical Research, vol. 13, no. 4, pp. 106–110, 2014. View at Publisher · View at Google Scholar
  30. B. M. Amarnath and M. Srinivas, “Method development and validation of RP-HPLC method for the simultaneous estimation of pantoprazole and ondansetron hydrochloride in bulk and in a synthetic mixture,” International Journal of PharmTech Research, vol. 6, no. 6, pp. 1794–1802, 2014. View at Google Scholar · View at Scopus
  31. D. T. King and J. T. Stewart, “HPLC determination of dacarbazine, doxorubicin, and ondansetron mixture in 5% dextrose injection on underivatized silica with an aqueous-organic mobile phase,” Journal of Liquid Chromatography & Related Technologies, vol. 16, no. 11, pp. 2309–2323, 1993. View at Publisher · View at Google Scholar · View at Scopus